Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland. Swiss Medical Weekly, [S. l.], v. 151, n. 0304, p. w20399, 2021. DOI: 10.4414/smw.2021.20399. Disponível em: https://smw.ch/index.php/smw/article/view/2940. Acesso em: 3 dec. 2025.